Product
BNT162b2 mRNA COVID-19 vaccine
Aliases
Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
2 clinical trials
1 indication
Indication
COVID-19Clinical trial
Effectiveness of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine on Symptomatic SARS-CoV-2 Infection and COVID-19-related Hospitalizations, Mortality, and Long-term Consequences in Brazil: a Real-world Evidence StudyStatus: Completed, Estimated PCD: 2022-06-20
Clinical trial
A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children Aged 5 to 11 Years in BrazilStatus: Completed, Estimated PCD: 2023-04-30